Literature DB >> 21124451

The Lkb1 metabolic sensor maintains haematopoietic stem cell survival.

Sushma Gurumurthy1, Stephanie Z Xie, Brinda Alagesan, Judith Kim, Rushdia Z Yusuf, Borja Saez, Alexandros Tzatsos, Fatih Ozsolak, Patrice Milos, Francesco Ferrari, Peter J Park, Orian S Shirihai, David T Scadden, Nabeel Bardeesy.   

Abstract

Haematopoietic stem cells (HSCs) can convert between growth states that have marked differences in bioenergetic needs. Although often quiescent in adults, these cells become proliferative upon physiological demand. Balancing HSC energetics in response to nutrient availability and growth state is poorly understood, yet essential for the dynamism of the haematopoietic system. Here we show that the Lkb1 tumour suppressor is critical for the maintenance of energy homeostasis in haematopoietic cells. Lkb1 inactivation in adult mice causes loss of HSC quiescence followed by rapid depletion of all haematopoietic subpopulations. Lkb1-deficient bone marrow cells exhibit mitochondrial defects, alterations in lipid and nucleotide metabolism, and depletion of cellular ATP. The haematopoietic effects are largely independent of Lkb1 regulation of AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling. Instead, these data define a central role for Lkb1 in restricting HSC entry into cell cycle and in broadly maintaining energy homeostasis in haematopoietic cells through a novel metabolic checkpoint.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21124451      PMCID: PMC3037591          DOI: 10.1038/nature09572

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  34 in total

1.  Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3.

Authors:  Ho-Jin Koh; David E Arnolds; Nobuharu Fujii; Thien T Tran; Marc J Rogers; Niels Jessen; Yangfeng Li; Chong Wee Liew; Richard C Ho; Michael F Hirshman; Rohit N Kulkarni; C Ronald Kahn; Laurie J Goodyear
Journal:  Mol Cell Biol       Date:  2006-09-11       Impact factor: 4.272

2.  The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.

Authors:  Reuben J Shaw; Katja A Lamia; Debbie Vasquez; Seung-Hoi Koo; Nabeel Bardeesy; Ronald A Depinho; Marc Montminy; Lewis C Cantley
Journal:  Science       Date:  2005-11-24       Impact factor: 47.728

3.  A ubiquitin-like system mediates protein lipidation.

Authors:  Y Ichimura; T Kirisako; T Takao; Y Satomi; Y Shimonishi; N Ishihara; N Mizushima; I Tanida; E Kominami; M Ohsumi; T Noda; Y Ohsumi
Journal:  Nature       Date:  2000-11-23       Impact factor: 49.962

4.  Regulation of reactive oxygen species by Atm is essential for proper response to DNA double-strand breaks in lymphocytes.

Authors:  Keisuke Ito; Keiyo Takubo; Fumio Arai; Hitoshi Satoh; Sahoko Matsuoka; Masako Ohmura; Kazuhito Naka; Masaki Azuma; Kana Miyamoto; Kentaro Hosokawa; Yasuo Ikeda; Tak W Mak; Toshio Suda; Atsushi Hirao
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

5.  Sucrose nonfermenting AMPK-related kinase (SNARK) mediates contraction-stimulated glucose transport in mouse skeletal muscle.

Authors:  Ho-Jin Koh; Taro Toyoda; Nobuharu Fujii; Michelle M Jung; Amee Rathod; R Jan-Willem Middelbeek; Sarah J Lessard; Jonas T Treebak; Katsuya Tsuchihara; Hiroyasu Esumi; Erik A Richter; Jørgen F P Wojtaszewski; Michael F Hirshman; Laurie J Goodyear
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

6.  Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation.

Authors:  Nabeel Bardeesy; Manisha Sinha; Aram F Hezel; Sabina Signoretti; Nathaniel A Hathaway; Norman E Sharpless; Massimo Loda; Daniel R Carrasco; Ronald A DePinho
Journal:  Nature       Date:  2002-09-12       Impact factor: 49.962

7.  LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1.

Authors:  Jose M Lizcano; Olga Göransson; Rachel Toth; Maria Deak; Nick A Morrice; Jérôme Boudeau; Simon A Hawley; Lina Udd; Tomi P Mäkelä; D Grahame Hardie; Dario R Alessi
Journal:  EMBO J       Date:  2004-02-19       Impact factor: 11.598

8.  Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease.

Authors:  Iris T Chan; Jeffery L Kutok; Ifor R Williams; Sarah Cohen; Lauren Kelly; Hirokazu Shigematsu; Leisa Johnson; Koichi Akashi; David A Tuveson; Tyler Jacks; D Gary Gilliland
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

9.  Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells.

Authors:  Daisuke Nakada; Thomas L Saunders; Sean J Morrison
Journal:  Nature       Date:  2010-12-02       Impact factor: 49.962

10.  Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells.

Authors:  Boyi Gan; Jian Hu; Shan Jiang; Yingchun Liu; Ergün Sahin; Li Zhuang; Eliot Fletcher-Sananikone; Simona Colla; Y Alan Wang; Lynda Chin; Ronald A Depinho
Journal:  Nature       Date:  2010-12-02       Impact factor: 49.962

View more
  204 in total

1.  Gene targeting RhoA reveals its essential role in coordinating mitochondrial function and thymocyte development.

Authors:  Shuangmin Zhang; Diamantis G Konstantinidis; Jun-Qi Yang; Benjamin Mizukawa; Khalid Kalim; Richard A Lang; Theodosia A Kalfa; Yi Zheng; Fukun Guo
Journal:  J Immunol       Date:  2014-11-14       Impact factor: 5.422

2.  Gfer is a critical regulator of HSC proliferation.

Authors:  Uma Sankar; Anthony R Means
Journal:  Cell Cycle       Date:  2011-07-15       Impact factor: 4.534

3.  The liver kinase B1 is a central regulator of T cell development, activation, and metabolism.

Authors:  Nancie J MacIver; Julianna Blagih; Donte C Saucillo; Luciana Tonelli; Takla Griss; Jeffrey C Rathmell; Russell G Jones
Journal:  J Immunol       Date:  2011-09-19       Impact factor: 5.422

Review 4.  Oxidants, metabolism, and stem cell biology.

Authors:  Jie Liu; Liu Cao; Toren Finkel
Journal:  Free Radic Biol Med       Date:  2011-10-18       Impact factor: 7.376

Review 5.  Staying alive: metabolic adaptations to quiescence.

Authors:  James R Valcourt; Johanna M S Lemons; Erin M Haley; Mina Kojima; Olukunle O Demuren; Hilary A Coller
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

Review 6.  Developmental decisions: balancing genetics and the environment by C. elegans.

Authors:  David V Tobin; Richard Mako Saito
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

7.  The ATM-BID pathway regulates quiescence and survival of haematopoietic stem cells.

Authors:  Maria Maryanovich; Galia Oberkovitz; Hagit Niv; Lidiya Vorobiyov; Yehudit Zaltsman; Ori Brenner; Tsvee Lapidot; Steffen Jung; Atan Gross
Journal:  Nat Cell Biol       Date:  2012-03-25       Impact factor: 28.824

8.  Metformin impairs the growth of liver kinase B1-intact cervical cancer cells.

Authors:  Xuxian Xiao; Qiongqiong He; Changming Lu; Kaitlin D Werle; Rui-Xun Zhao; Jianfeng Chen; Ben C Davis; Rutao Cui; Jiyong Liang; Zhi-Xiang Xu
Journal:  Gynecol Oncol       Date:  2012-06-24       Impact factor: 5.482

9.  AMPKα1-LDH pathway regulates muscle stem cell self-renewal by controlling metabolic homeostasis.

Authors:  Marine Theret; Linda Gsaier; Bethany Schaffer; Gaëtan Juban; Sabrina Ben Larbi; Michèle Weiss-Gayet; Laurent Bultot; Caterina Collodet; Marc Foretz; Dominique Desplanches; Pascual Sanz; Zizhao Zang; Lin Yang; Guillaume Vial; Benoit Viollet; Kei Sakamoto; Anne Brunet; Bénédicte Chazaud; Rémi Mounier
Journal:  EMBO J       Date:  2017-05-17       Impact factor: 11.598

10.  Tuberous sclerosis 1 (Tsc1)-dependent metabolic checkpoint controls development of dendritic cells.

Authors:  Yanyan Wang; Gonghua Huang; Hu Zeng; Kai Yang; Richard F Lamb; Hongbo Chi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.